

EudraCT Number:          2020-001331-26
Sponsor Protocol Number: PROLIFIC2020
Sponsor Name:            Cambridge University Hospitals NHS Foundation Trust
Full Title:              ChemoPROphyLaxIs For covId-19 infeCtious disease (the PROLIFIC trial)
Start Date:              2020-04-14
Medical condition:       Coronavirus disease 2019 (COVID-19) caused by the infection, SARS-CoV-2
Disease:                 Version: 20.0, SOC Term: 100000004862, Classification Code: 10051905, Term: Coronavirus infection, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001331-26

EudraCT Number:          2020-001402-38
Sponsor Protocol Number: CTU/2020/352
Sponsor Name:            University College London
Full Title:              An international, Bayesian platform adaptive, randomized, placebo-controlled trial assessing the effectiveness of candidate interventions in preventing COVID-19 disease in healthcare workers.
Start Date:              2020-10-20
Medical condition:       Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10084268, Term: COVID-19, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001402-38

EudraCT Number:          2020-001889-10
Sponsor Protocol Number: STOIC
Sponsor Name:            University of Oxford, Clinical Trials and Research Governance
Full Title:              Use of inhaled corticosteroids as treatment of early COVID-19 infection to prevent clinical deterioration and hospitalisation
Start Date:              2020-06-02
Medical condition:       COVID 19
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001889-10

EudraCT Number:          2020-001777-71
Sponsor Protocol Number: RAVEN
Sponsor Name:            Guy’s and St Thomas' NHS Foundation Trust
Full Title:              Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patiENts - RAVEN
Start Date:              2020-05-06
Medical condition:       Severe COVID-19 infection with risk of need for mechanical ventilation.
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10084382, Term: Coronavirus disease 2019, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001777-71

EudraCT Number:          2020-001740-26
Sponsor Protocol Number: ATOMIC2
Sponsor Name:            University of Oxford, Clinical Trials and Research Governance
Full Title:              A multi-centre open-label two-arm randomised superiority clinical trial of Azithromycin versus usual care In Ambulatory COVID-19 (ATOMIC2)
Start Date:              2020-05-05
Medical condition:       COVID-19
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Disease:                 Version: 20.0, SOC Term: 10022891 - Investigations, Classification Code: 10070255, Term: Coronavirus test positive, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001740-26

EudraCT Number:          2020-002110-41
Sponsor Protocol Number: CRUKD/20/002
Sponsor Name:            Cancer Research UK
Full Title:              SPIKE-1 TRIAL: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated memb...
Start Date:              2020-06-18
Medical condition:       COVID-19
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002110-41

EudraCT Number:          2020-001597-30
Sponsor Protocol Number: MRx-4DP0004-II-001
Sponsor Name:            4D pharma plc
Full Title:              A pilot, multiple dose study to evaluate the efficacy and safety of MRx-4DP0004 in hospitalised patients with symptoms of COVID-19 (SARS-CoV-2 infection)
Start Date:              2020-05-29
Medical condition:       Symptoms of Covid-19 infection
Disease:                 Version: 20.0, SOC Term: 100000004862, Classification Code: 10061986, Term: SARS, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001597-30

EudraCT Number:          2020-001750-22
Sponsor Protocol Number: 20HH5926
Sponsor Name:            Joint Research Compliance Office
Full Title:              MATIS: Phase 2/3, Randomised, Open-Label, Single-Site, Multi-Arm Trial of Ruxolitinib Plus Best Supportive Treatment (BST) versus Fostamatinib Plus BST versus BST for COVID-19 pneumonia
Start Date:              2020-07-09
Medical condition:       COVID-19 pneumonia
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001750-22

EudraCT Number:          2020-001448-24
Sponsor Protocol Number: RG_20-029COVID-19
Sponsor Name:            University of Birmingham
Full Title:              Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19 
Start Date:              2020-04-15
Medical condition:       Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19
Disease:                 Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10035664, Term: Pneumonia, Level: PT
Disease:                 Version: 21.1, SOC Term: 100000004855, Classification Code: 10003083, Term: ARDS, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24

EudraCT Number:          2020-001721-31
Sponsor Protocol Number: SPON-AK-0420
Sponsor Name:            Hampshire Hospitals NHS TRust
Full Title:              Can a sinus rinse and mouth wash reduce viral load in COVID-19 positive individuals?
Start Date:              2020-05-01
Medical condition:       Covid-19
Disease:                 Version: 20.0, SOC Term: 100000004862, Classification Code: 10061986, Term: SARS, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001721-31

EudraCT Number:          2020-003628-18
Sponsor Protocol Number: 000000
Sponsor Name:            University of Oxford, Clinical Trials and Research Governance
Full Title:              Adalimumab in COVID-19 to present respiratory failure in community care (AVID-CC): A randomised controlled trial
Start Date:              2020-09-29
Medical condition:       COVID-19
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Disease:                 Version: 20.0, SOC Term: 10022891 - Investigations, Classification Code: 10070255, Term: Coronavirus test positive, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003628-18

EudraCT Number:          2020-001937-11
Sponsor Protocol Number: 132333
Sponsor Name:            University College London
Full Title:              A single-site, randomised, controlled, parallel design, open-label investigation of an approved nebulised recombinant human DNase enzyme (dornase alfa) to reduce hyperinflammation in hospitalised p...
Start Date:              2020-04-30
Medical condition:       Respiratory illness caused by Covid-19
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001937-11

EudraCT Number:          2020-001904-41
Sponsor Protocol Number: GETAFIX-2020
Sponsor Name:            NHS Greater Glasgow and Clyde
Full Title:              Glasgow Early Treatment Arm FavIpiravir : A randomized controlled study of favipiravir as an early treatment arm in COVID-19 patients
Start Date:              2020-05-20
Medical condition:       COVID-19
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adolescents, Under 18, Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001904-41

EudraCT Number:          2020-002120-37
Sponsor Protocol Number: RESP301-002
Sponsor Name:            Thirty Respiratory Limited
Full Title:              An open-label, adaptive randomized, controlled multicenter study to evaluate the efficacy and safety of RESP301 plus standard of care (SOC) compared to SOC alone in hospitalized participants with C...
Start Date:              2020-06-16
Medical condition:       Coronavirus disease 2019 (COVID-19) 
Disease:                 Version: 20.0, SOC Term: 100000004862, Classification Code: 10061986, Term: SARS, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002120-37

EudraCT Number:          2020-005395-35
Sponsor Protocol Number: GatesMRI-COD-01-T01-01
Sponsor Name:            Bill & Melinda Gates Medical Research Institute
Full Title:              A randomized, controlled, Phase 2b study to evaluate safety and efficacy of rivaroxaban (Xarelto®) for high risk people with mild COVID-19 
Start Date:              2020-12-16
Medical condition:       Mild COVID-19 in people who are at high risk for moderate or severe disease due to age, body mass index (BMI) and comorbidities, many of which are also thrombotic risks. 

Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005395-35

EudraCT Number:          2020-001072-15
Sponsor Protocol Number: COV001
Sponsor Name:            University of Oxford
Full Title:              A phase I/II study to determine efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in UK healthy adult volunteers
Start Date:              2020-03-26
Medical condition:       COVID-19
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adults
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001072-15

EudraCT Number:          2020-004123-16
Sponsor Protocol Number: 2019nCoV-302
Sponsor Name:            Novavax, Inc.
Full Title:              A Phase 3, Randomised, Observer-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) with Matrix-M1™ ...
Start Date:              2020-09-23
Medical condition:       Prevention of COVID-19 caused by SARS-CoV-2
Disease:                 Version: 23.1, SOC Term: 100000004865, Classification Code: 10084465, Term: COVID-19 vaccination, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004123-16

EudraCT Number:          2020-001502-38
Sponsor Protocol Number: VP-C21-006
Sponsor Name:            Vicore Pharma AB
Full Title:              A randomised, double blind, placebo controlled, Phase 2 trial investigating the safety and efficacy of C21 in hospitalised subjects with COVID-19 infection not requiring mechanical ventilation 
Start Date:              2020-05-06
Medical condition:       Covid-19 infection
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(Completed) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001502-38

EudraCT Number:          2020-001209-22
Sponsor Protocol Number: PRINCIPLE
Sponsor Name:            University of Oxford / Clinical Trials and Research Governance 
Full Title:              Platform Randomised trial of INterventions against COVID-19 In older peoPLE
Start Date:              2020-03-26
Medical condition:       Suspected COVID-19
Disease:                 Version: 23.0, SOC Term: 100000004862, Classification Code: 10053983, Term: Corona virus infection, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001209-22

EudraCT Number:          2020-001640-26
Sponsor Protocol Number: 132151
Sponsor Name:            University College London
Full Title:              A pilot, open label, phase II clinical trial of nebulised recombinant tissue-Plasminogen Activator (rtPA)in patients with COVID-19 ARDS: The Plasminogen Activator COVID-19 ARDS (PACA) trial  
Start Date:              2020-04-17
Medical condition:       Acute respiratory distress syndrome (ARDS) caused by COVID-19 
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001640-26

EudraCT Number:          2020-001886-35
Sponsor Protocol Number: RHMCRI0399
Sponsor Name:            University Hospital Southampton NHS Foundation Trust
Full Title:              A clinical trial of nebulized surfactant for the Treatment of moderate to severe COVID-19 in adults
Start Date:              2020-05-15
Medical condition:       COVID-19 infection in patients requiring endotrachael intubation
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001886-35

EudraCT Number:          2020-002476-13
Sponsor Protocol Number: 20HH5958
Sponsor Name:            Imperial College London
Full Title:              A study to assess the safety and efficacy of Clazakizumab in patients with COVID-19 and kidney disease. 
Start Date:              2020-07-24
Medical condition:       Patients with kidney disease who are hospitalised with COVID-19 infection with pulmonary involvement (i.e. consistent chest imaging abnormalities) and clinical deterioration (i.e increasing oxygen ...
Disease:                 Version: 20.0, SOC Term: 100000004857, Classification Code: 10023417, Term: Kidney dysfunction, Level: LLT
Disease:                 Version: 20.0, SOC Term: 100000004862, Classification Code: 10047463, Term: Viral infection NOS, Level: LLT
Disease:                 Version: 20.0, SOC Term: 10022891 - Investigations, Classification Code: 10063321, Term: Interleukin level, Level: PT
Disease:                 Version: 20.1, SOC Term: 10041244 - Social circumstances, Classification Code: 10079637, Term: Dependence on oxygen therapy, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002476-13

EudraCT Number:          2020-004144-28
Sponsor Protocol Number: CCTU0307
Sponsor Name:            Cambridge university Hosptials NHS Foundation Trust and University of Cambridge
Full Title:              PROphylaxis for paTiEnts at risk of COVID-19 infecTion
Start Date:              2020-10-23
Medical condition:       
Disease:
Population Age:          
Gender:                  
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004144-28

EudraCT Number:          2020-004994-27
Sponsor Protocol Number: 2020SW03
Sponsor Name:            Ashford and St Peter's Hospitals NHS Foundation Trust
Full Title:              Clinical Efficacy of Nitric Oxide Nasal Spray (NONS) for the Treatment of Mild COVID-19 Infection
Start Date:              2020-12-16
Medical condition:       COVID-19
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004994-27

EudraCT Number:          2020-001805-21
Sponsor Protocol Number: RA486120
Sponsor Name:            University Hospital Coventry & Warwickshire
Full Title:              Prospective, Randomized, Parallel-Group, Open-Label Study to Evaluate the Efficacy and Safety of IMU-838, in Combination with Oseltamivir, in Adults with Coronavirus Disease COVID-19 
Start Date:              2020-05-15
Medical condition:       Sars-Cov-2
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001805-21

EudraCT Number:          2020-001228-32
Sponsor Protocol Number: COV002
Sponsor Name:            CTRG
Full Title:              A phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19
Start Date:              2020-05-04
Medical condition:       SARS-CoV-2
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001228-32

EudraCT Number:          2020-001449-38
Sponsor Protocol Number: CW002
Sponsor Name:            Chelsea and Westminster Hospital NHS Foundation Trust
Full Title:              A Randomised Controlled Trial of Early Intervention in Patients HospItalised with COVID-19: Favipiravir verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe 
Start Date:              2020-04-29
Medical condition:       COVID-19 Infection
Disease:                 Version: 20.0, SOC Term: 100000004862, Classification Code: 10051905, Term: Coronavirus infection, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001449-38

EudraCT Number:          2020-002567-57
Sponsor Protocol Number: 1.0
Sponsor Name:            University of Oxford / Clinical Trials and Research Governance
Full Title:              To determine whether administration of almitrine bismesylate can ameliorate hypoxaemia in Covid-19 and augment effectiveness of supplementary oxygen therapy and respiratory support
Start Date:              2020-11-23
Medical condition:       Covid-19
Disease:                 Version: 21.1, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10001053, Term: Acute respiratory failure, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002567-57

EudraCT Number:          2020-002668-29
Sponsor Protocol Number: 132796
Sponsor Name:            University College London
Full Title:              A Randomised Controlled Trial of plasma exchange with standard of care compared to standard of care alone in the treatment of severe COVID-19 infection (COVIPLEX)  
Start Date:              2020-06-25
Medical condition:       COVID-19
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002668-29

EudraCT Number:          2020-001996-33
Sponsor Protocol Number: CD12_COVID-19
Sponsor Name:            CytoDyn, Inc.
Full Title:              A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients with Severe or Critical Coronavirus Disease 2019 (CO...
Start Date:              2020-08-26
Medical condition:       Coronavirus Disease 2019 (COVID-19)
Disease:                 Version: 23.0, SOC Term: 100000004862, Classification Code: 10053983, Term: Corona virus infection, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001996-33

EudraCT Number:          2020-002106-68
Sponsor Protocol Number: CTU/2020/354
Sponsor Name:            University College London Comprehensive Clinical Trial Unit
Full Title:              Favipiravir, lopinavir/ritonavir or combination therapy: a randomised, double blind, 2x2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
Start Date:              2020-07-16
Medical condition:       SARS-CoV-2 (Corona virus) infection
Disease:                 Version: 23.0, SOC Term: 100000004862, Classification Code: 10053983, Term: Corona virus infection, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002106-68

EudraCT Number:          2020-001643-13
Sponsor Protocol Number: 01.01.20
Sponsor Name:            University of Dundee
Full Title:              A randomised double-blind placebo-controlled trial of Brensocatib (INS1007) in patients with severe COVID-19 
Start Date:              2020-05-15
Medical condition:       COVID-19
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adolescents, Under 18, Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001643-13

EudraCT Number:          2020-002230-32
Sponsor Protocol Number: 
Sponsor Name:            University of Edinburgh
Full Title:              Rapid Experimental Medicine for COVID-19 
Start Date:              2020-06-23
Medical condition:       COVID-19
Disease:
Population Age:          Under 18, Adults
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002230-32

EudraCT Number:          2020-001636-95
Sponsor Protocol Number: 282110
Sponsor Name:            University of Manchester
Full Title:              Subcutaneous and Intravenous anakinra in COVID-19 Infection -  Feasibility & Pharmacokinetics/ Pharmacodynamics study
Start Date:              2020-05-20
Medical condition:       Suspected or confirmed SARS-CoV-2 infection (confirmed by RNA-PCR)
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001636-95

EudraCT Number:          2020-002229-27
Sponsor Protocol Number: TACTIC-E
Sponsor Name:            Cambridge University Hospitals NHS Foundation Trust
Full Title:              mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 – Experimental drugs and mechanisms  
Start Date:              2020-06-09
Medical condition:       SARS-Cov-2
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002229-27

EudraCT Number:          2020-001023-14
Sponsor Protocol Number: SG016
Sponsor Name:            Synairgen Research Limited
Full Title:              A randomised double-blind placebo-controlled trial to determine the safety and efficacy of inhaled SNG001 (IFNβ-1a for nebulisation) for the treatment of patients with confirmed SARS-CoV-2 infectio...
Start Date:              2020-03-17
Medical condition:       COVID-19
Disease:                 Version: 20.0, SOC Term: 100000004862, Classification Code: 10051905, Term: Coronavirus infection, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001023-14

EudraCT Number:          2020-004719-28
Sponsor Protocol Number: D8850C00003
Sponsor Name:            AstraZeneca AB
Full Title:              A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 a...
Start Date:              2020-11-20
Medical condition:       COVID-19
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004719-28

EudraCT Number:          2020-001786-36
Sponsor Protocol Number: ILIAD-7-UK-Cohort
Sponsor Name:            RevImmune SAS France
Full Title:              Recombinant InterLeukin-7 (CYT107) to Improve clinical outcomes in lymphopenic pAtients with COVID-19 infection “ILIAD 7 trial”
Start Date:              2020-05-06
Medical condition:       Lymphopenia and T cell exhaustion in  COVID-19 patients
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001786-36

EudraCT Number:          2020-001354-22
Sponsor Protocol Number: TACTIC-R
Sponsor Name:            Cambridge University Hospitals NHS Foundation Trust
Full Title:              Multiarm Therapeutic study in pre-ICU patients admitted with COVID-19 - Repurposed Drugs (TACTIC-R)
Start Date:              2020-05-06
Medical condition:       COVID-19-related complications
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001354-22

EudraCT Number:          2020-001473-79
Sponsor Protocol Number: ESR-20-20653
Sponsor Name:            Saint Luke’s Hospital of Kansas City, Kansas City, Missouri, USA
Full Title:              An International, Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Dapagliflozin in Respiratory Failure in Patients with COVID-19
Start Date:              2020-05-07
Medical condition:       Respiratory Failure in patients with COVID-19
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001473-79

EudraCT Number:          2020-001860-27
Sponsor Protocol Number: UoL001542
Sponsor Name:            University of Liverpool
Full Title:              AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment
Start Date:              2020-05-12
Medical condition:       Coronavirus-induced disease (COVID-19) (SARS coronavirus 2, or SARS-CoV-2)
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001860-27

EudraCT Number:          2020-001684-89
Sponsor Protocol Number: RG_20-030
Sponsor Name:            University of Birmingham
Full Title:              CATALYST - A randomised phase II proof of principle multi-arm multi-stage trial designed to guide the selection of interventions for phase III trials in hospitalised patients with COVID-19 infection.
Start Date:              2020-05-05
Medical condition:       COVID-19
Disease:                 Version: 20.1, SOC Term: 100000004855, Classification Code: 10047468, Term: Viral lower respiratory tract infections, Level: HLT
Population Age:          Adolescents, Under 18, Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001684-89

EudraCT Number:          2020-001203-16
Sponsor Protocol Number: LIBERATE
Sponsor Name:            Guy's and St Thomas' NHS Foundation Trust
Full Title:              Lipid ibuprofen versus standard of care for acute hypoxaemic respiratory failure due to COVID-19: a multicentre, randomised, controlled trial
Start Date:              2020-05-06
Medical condition:       COVID-19; respiratory failure; hypoxaemia.
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Disease:                 Version: 21.1, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10001053, Term: Acute respiratory failure, Level: PT
Disease:                 Version: 20.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10021141, Term: Hypoxaemia, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001203-16

EudraCT Number:          2020-001113-21
Sponsor Protocol Number: NDPHRECOVERY
Sponsor Name:            University of Oxford
Full Title:              Randomised Evaluation of COVID-19 Therapy (RECOVERY)
Start Date:              2020-03-17
Medical condition:       COVID-19 (infection with SARS-CoV-2 virus)
Disease:                 Version: 21.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10035737, Term: Pneumonia viral, Level: PT
Disease:                 Version: 20.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10061982, Term: Severe acute respiratory syndrome, Level: PT
Population Age:          Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001113-21

EudraCT Number:          2020-002952-18
Sponsor Protocol Number: Protocol
Sponsor Name:            Ashford and St Peter's Hospitals NHS Foundation Trust
Full Title:              Targeting de novo Pyrimidine Biosynthesis by leflunomide as a Novel Concept for the Treatment of Corona Virus Disease 2019 (COVID-19)
Start Date:              2020-07-21
Medical condition:       Confirmed Covid-19 infection by RT-PCR
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002952-18

EudraCT Number:          2020-000483-27
Sponsor Protocol Number: CCT38473
Sponsor Name:            St.  Joseph’s  Healthcare,  McMaster  University
Full Title:              Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis in ICU
Start Date:              2020-11-19
Medical condition:       critical illness requiring mechanical ventilation
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000483-27

EudraCT Number:          2020-001396-33
Sponsor Protocol Number: EPA-COV-001
Sponsor Name:            SLA Pharma (UK) Ltd
Full Title:              A randomised, double-blind, placebo-controlled study of eicosapentaenoic acid (EPA-FFA) gastro-resistant capsules to treat hospitalised subjects with confirmed SARS-CoV-2
Start Date:              2020-11-13
Medical condition:       SARS-CoV-2
Disease:                 Version: 23.0, SOC Term: 100000004862, Classification Code: 10084272, Term: SARS-CoV-2 infection, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001396-33

EudraCT Number:          2020-002494-10
Sponsor Protocol Number: 
Sponsor Name:            Queen Mary University of London
Full Title:              Personalised Electronic Record Supported OptimisatioN when ALone  for Patients with Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic 
Start Date:              2020-07-17
Medical condition:       Hypertension
Disease:                 Version: 21.1, SOC Term: 100000004866, Classification Code: 10081425, Term: Arterial hypertension, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002494-10

EudraCT Number:          2020-001736-95
Sponsor Protocol Number: ACCORD-2-001,Sub002,003,006
Sponsor Name:            University Hospital Southampton NHS Foundation Trust
Full Title:              ACCORD 2: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID 19 in Hospitalised Patients 
Start Date:              2020-04-28
Medical condition:       COVID 19 
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001736-95

EudraCT Number:          2020-003486-19
Sponsor Protocol Number: 1.002.20
Sponsor Name:            University of Dundee
Full Title:              A randomised, double-blind, placebo-controlled trial of SFX-01 or placebo on a backbone of best standard care, to improve outcomes in patients with community acquired pneumonia and suspected or con...
Start Date:              2020-10-08
Medical condition:       Community acquired pneumonia with suspected or confirmed SARS-CoV-2 infection
Disease:                 Version: 20.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10066724, Term: Acute pneumonia, Level: LLT
Disease:                 Version: 20.1, SOC Term: 10021881 - Infections and infestations, Classification Code: 10010120, Term: Community acquired pneumonia, Level: LLT
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10084380, Term: COVID-19 pneumonia, Level: PT
Disease:                 Version: 21.1, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10001052, Term: Acute respiratory distress syndrome, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003486-19

EudraCT Number:          2020-001441-39
Sponsor Protocol Number: VIR20001
Sponsor Name:            University of Oxford
Full Title:              Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)
Start Date:              2020-05-12
Medical condition:       COVID-19, acute respiratory illness
Disease:                 Version: 23.0, SOC Term: 100000004862, Classification Code: 10053983, Term: Corona virus infection, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) IT(Prematurely Ended) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001441-39

EudraCT Number:          2020-002503-19
Sponsor Protocol Number: 62586
Sponsor Name:            UMC Utrecht
Full Title:              BCG vaccination to Reduce the impact of COVID-19 in healthcare workers (BRACE) Trial 
Start Date:              2020-07-08
Medical condition:       SARS-CoV-2 infection
Disease:                 Version: 20.0, SOC Term: 100000004848, Classification Code: 10047490, Term: Virus identification and serology, Level: HLT
Population Age:          Adults
Gender:                  Male, Female
Trial protocol:          NL(Completed) GB(GB - no longer in EU/EEA) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002503-19

EudraCT Number:          2020-001803-17
Sponsor Protocol Number: GS-US-540-5823
Sponsor Name:            Gilead Sciences Inc.
Full Title:              A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants from Birth to < 18 Years of Age with COVID-19
Start Date:              2020-07-14
Medical condition:       Coronavirus disease 2019 (COVID-19)
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Newborns, Infants and toddlers, Children, Adolescents, Under 18
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) IT(Ongoing) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001803-17

EudraCT Number:          2020-003643-29
Sponsor Protocol Number: VAC31518COV3009
Sponsor Name:            Janssen Vaccines & Prevention B.V.  
Full Title:              A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older  E...
Start Date:              2020-11-10
Medical condition:       Healthy Volunteers, with or without comorbidities (Prevention of SARS-CoV-2-mediated COVID-19)
Disease:                 Version: 23.1, SOC Term: 100000004865, Classification Code: 10084465, Term: COVID-19 vaccination, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) FR(Ongoing) DE(Ongoing) ES(Temporarily Halted) BE(Ongoing) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003643-29

EudraCT Number:          2020-002211-21
Sponsor Protocol Number: SGS.1656.201
Sponsor Name:            St George Street Capital Ltd
Full Title:              A Phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in diabetic patients hospitalised with suspected or confirmed COVID-19. The ARCA...
Start Date:              2020-07-31
Medical condition:       COVID-19
Disease:                 Version: 23.0, SOC Term: 100000004862, Classification Code: 10084382, Term: Coronavirus disease 2019, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) CZ(Completed) RO(Completed) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002211-21

EudraCT Number:          2020-002542-16
Sponsor Protocol Number: INSIGHT013
Sponsor Name:            Office of Sponsored Projects, Regents of the University of Minnesota
Full Title:              An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the...
Start Date:              2020-09-30
Medical condition:       COVID-19 (SARS-CoV-2) infection
Disease:                 Version: 23.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10051905, Term: Coronavirus infection, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) GR(Completed) DK(Completed) DE(Completed) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002542-16

EudraCT Number:          2020-003125-39
Sponsor Protocol Number: TRI-08892
Sponsor Name:            Thrombosis Research Institute
Full Title:              Early thromboprophylaxis in COVID-19 (ETHIC trial): an open label, randomized phase IIIb trial of community-based prophylactic low-molecular-weight heparin (LMWH) versus standard of care (no enoxap...
Start Date:              2020-10-12
Medical condition:       Confirmed diagnosis of SARS-CoV-2  with symptomatic COVID-19 infection 
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          BE(Completed) GB(GB - no longer in EU/EEA) DE(Prematurely Ended) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003125-39

EudraCT Number:          2020-001497-30
Sponsor Protocol Number: ALXN1210-COV-305
Sponsor Name:            Alexion Pharmaceuticals, Inc.
Full Title:              COVID-19 A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-1...
Start Date:              2020-05-07
Medical condition:       COVID-19 severe pneumonia, acute lung injury, or acute respiratory distress syndrome
Disease:                 Version: 20.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10061229, Term: Lung infection, Level: PT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          GB(GB - no longer in EU/EEA) FR(Prematurely Ended) DE(Prematurely Ended) ES(Temporarily Halted) IT(Ongoing) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30

EudraCT Number:          2020-003368-24
Sponsor Protocol Number: MK-4482-002
Sponsor Name:            Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Full Title:              A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Non-Hospitalized Adults with COVID-19
Start Date:              2020-11-18
Medical condition:       COVID-19
Disease:                 Version: 23.0, SOC Term: 100000004862, Classification Code: 10084382, Term: Coronavirus disease 2019, Level: LLT
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          FR(Completed) GB(GB - no longer in EU/EEA) DE(Completed) IT(Completed) PL(Completed) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003368-24

EudraCT Number:          2020-001689-12
Sponsor Protocol Number: MHIPS-2020-001
Sponsor Name:            MONTREAL HEART INSTITUTE
Full Title:              COLCHICINA TEST IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19)
Start Date:              2020-04-11
Medical condition:       Men and women over 40 years of age, with a diagnosis of COVID-19 infection and at least one high risk criterion.
Disease:
Population Age:          Adults, Elderly
Gender:                  Male, Female
Trial protocol:          ES(Ongoing) GB(GB - no longer in EU/EEA) FR(Prematurely Ended) GR(Prematurely Ended) 
Link:                    https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12